Home/ Supplements/ Niacin/ Lipid Balance

Lipid Balance

product on market Capsule Progressive Professional from Progressive Laboratories Safety: 94/100
94/100

This product looks safe

  • Vitamin B3: 460mg is 13.1× the Tolerable Upper Intake Level (35mg)
  • 67% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Red yeast rice and vitamin B3 are supported by strong evidence for managing lipid levels. Curcumin and Seanol-P show moderate evidence for supporting metabolic health and inflammatory responses. Together, these ingredients target cardiovascular wellness through various biochemical pathways.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Vitamin B3: 460mg is 13.1× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Lipid Balance
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Vegetable Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

460 mg (2300% DV)
Exceeds UL by 13.1× (UL: 35 mg) 196 studies (A:5, B:63)
Market median: 1000.0mg (223 products) 11 studies (A:0, B:5)
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
Market median: 450.0mg (254 products) 243 studies (A:0, B:100)
Seanol-P
15 mg
Bioperine
3 mg

Other Ingredients

Rice Flour Silica Hydroxypropylmethylcellulose Monostearin
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Three vegetable capsules twice daily or 2 capsules three times daily with meals, or as directed by a health care professional.

Warnings & Precautions

Do not use if you are pregnant, may become pregnant, or are breast feeding, because using this product may cause birth defects.

Tamper evident band around cap and seal on bottle. Do not use if either seal is broken or missing.

Keep out of reach of children.

Contains: soy.

Formulation Notes

Clinically formulated to support normal range blood lipid levels.

Progressive Laboratories manufactured this product in its 3rd party GMP-inspected facility. (Good Manufacturing Practices)

Additional Information

Sold only for dispensing by a licensed health care professional.

Formulated by Mitchell A. Fleisher, M.D., D.Ht., D.A.B.F.M., Dc.A.B.C.T.

Certified GMP Compliant GMP Good Manufacturing Practice 21 CFR 111

Metadata

Product Details

UPC / SKU3 51821 01051 9
DSLD Entry Date2022-04-11
Product TypeOther Combinations
FormCapsule
DSLD ID261242
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.